COVID-19 resources for providers

Nebraska Medicine and the University of Nebraska Medical Center have led the world in treatment, training and quarantine methods for highly infectious diseases since caring for patients during the 2014 Ebola outbreak. 

Personal protective equipment (PPE):

Protocols and checklists (COVID-19):

Guidance documents (COVID-19):

Region VII DHRE webinar:

Additional resources: 

Additional information:

The first U.S. COVID-19-related study – a NIH sponsored randomized, controlled trial of the antiviral medication (Remdesivir) – began at Nebraska Medical Center Feb. 25. Andre Kalil, MD, an infectious diseases specialist and professor of internal medicine at Nebraska Medicine/UNMC, is leading the clinical trial.